Skip to main content

Table 2 Staging of the disease

From: Trends and results in treatment of gastric cancer over last two decades at single East European centre: a cohort study

Parameter

Group I

Group II

P value

Pathological stage

   

  T1

21 (7.7%)

39 (13.7%)

0.042

  T2

42 (15.4%)

101 (35.6%)

0.0001

  T3

118 (43.2%)

116 (40.8%)

0.775

  T4

92 (33.7%)

28 (9.9%)

0.0001

N stage

   

  N0

86 (31.5%)

91 (32.0%)

0.931

  N1

68 (24.9%)

87 (30.6%)

0.276

  N2

92 (33.7%)

73 (25.7%)

0.133

  N3

27 (9.9%)

33 (11.6%)

0.589

TNM Stage

   

  IA

18 (6.6%)

30 (10.6%)

0.135

  IB

30 (11.0%)

47 (16.5%)

0.114

  IIA

43 (15.8%)

61 (21.5%)

0.165

  IIB

51 (18.7%)

47 (16.5%)

0.586

  IIIA

58 (21.2%)

65 (22.9%)

0.765

  IIIB

51 (18.7%)

24 (8.5%)

0.002

  IIIC

22 (8.1%)

10 (3.5%)

0.044